Infant Bacterial Therapeutics AB publ announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced operating loss was SEK 27.428 million compared to SEK 23.837 million a year ago. Net loss was SEK 27.535 million compared to SEK 24.143 million a year ago. Basic loss per share was SEK 2.45 compared to SEK 2.15 a year ago. For the full year, operating loss was SEK 47.200 million compared to SEK 39.417 million a year ago. Net loss was SEK 46.320 million compared to SEK 40.607 million a year ago. Basic loss per share was SEK 4.13 compared to SEK 3.76 a year ago.